HeartSciences Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
HSCS Nasdaq 3840 heartsciences.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for HeartSciences Inc.

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results - Dec 16th, 2024 9:15 pm
HeartSciences’ AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement - Nov 13th, 2024 2:00 pm
HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit - Oct 14th, 2024 8:15 pm
HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results - Sep 12th, 2024 8:15 pm
HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission - Sep 12th, 2024 1:00 pm
HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results - Jul 29th, 2024 8:05 pm
Innovation Value Institute Analysis Demonstrates HeartSciences’ MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency - Jul 26th, 2024 1:00 pm
HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare - Jul 25th, 2024 12:30 pm
HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction - Jul 11th, 2024 1:00 pm
HeartSciences Regains Compliance with Nasdaq Listing Requirements - Jun 4th, 2024 8:15 pm
HeartSciences Announces Further Internationalization of its AI-ECG Patent Portfolio - May 20th, 2024 1:00 pm
HeartSciences Announces Grant of Fundamental Patent by the European Patent Office Covering Assessment of Diastolic Function of the Heart Using AI-ECG - Apr 24th, 2024 1:00 pm
HeartSciences to Present at the LD Micro Invitational XIV Conference - Apr 2nd, 2024 8:15 pm
HeartSciences Announces Podium Presentation at World Congress of Anesthesiologists on the Utility of MyoVista® Wavelet ECG For Detection of Left Ventricular Diastolic Dysfunction in Preoperative Patients - Mar 26th, 2024 1:00 pm
Heart Test Laboratories Third Quarter 2024 Earnings: US$0.031 loss per share (vs US$0.16 loss in 3Q 2023) - Mar 16th, 2024 1:44 pm
HeartSciences Reports Third Quarter Fiscal 2024 Financial Results - Mar 14th, 2024 8:15 pm
HeartSciences’ Announces Peer-Reviewed Publication Evaluating Use of MyoVista® Technology to Detect Asymptomatic Left Ventricular Dysfunction in Patients with Type 2 Diabetes - Mar 12th, 2024 1:00 pm
HeartSciences Announces Canada Patent Grant Covering MyoVista® Wavelet Technology - Mar 6th, 2024 2:00 pm
HeartSciences Adds Key Advisor to its Scientific Advisory Board - Feb 26th, 2024 2:00 pm
HeartSciences Expands its Scientific Advisory Board - Feb 12th, 2024 2:00 pm